Marker Therapeutics Inc (MRKR)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3200 SOUTHWEST FREEWAY HOUSTON, TX 77027

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker's cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. This population of T cells is designed to attack multiple tumor targets following infusion into patients and to activate the patient's immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cell therapies, the company believes that its product candidates will be easier and less expensive to manufacture, with reduced toxicities, compared to current engineered CAR-T and TCR-based approaches, and may provide patients with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling product profile, as compared to current gene-modified CAR-T and TCR-based therapies.

Data as of 2021-09-19 12:40:20 -0400
Market Cap152.865 Million Shares Outstanding83.079 Million Avg 30-day Volume343.921 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-3.41 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.51035 52-week High/Low3.77 / 1.32 Next Earnings Date2021-11-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from MRKR instead.

View recent insider trading info

Funds Holding MRKR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MRKR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ELMS STEVE

  • Director
3,172,537 2021-06-08 3

EANSOR NORMAN DAVID

  • Director
36,940 2021-06-08 2

WASSERMAN FREDERICK GERALD

  • Director
65,223 2021-06-08 3

LASKOW-POOLEY DAVID

  • Director
55,223 2021-06-08 2

WILSON JOHN ROBERT

  • Director
7,812,008 2021-06-08 3

MAKOWER JOSHUA

  • 10% Owner
10,714,285 2021-03-16 1

SANDELL SCOTT D

  • 10% Owner
10,714,285 2021-03-16 1

BASKETT FOREST

  • 10% Owner
10,714,285 2021-03-16 1

WALKER PAUL EDWARD

  • 10% Owner
10,714,285 2021-03-16 1

SONSINI PETER W.

  • 10% Owner
10,714,285 2021-03-16 1

FLORENCE ANTHONY A. JR.

  • 10% Owner
10,714,285 2021-03-16 1

BEHBAHANI ALI

  • 10% Owner
10,714,285 2021-03-16 1

HOANG PETER L. PRESIDENT AND CEO

  • Officer
  • Director
332,568 2021-03-16 2

MAKHZOUMI MOHAMAD

  • 10% Owner
10,714,285 2021-03-16 1

NEW ENTERPRISE ASSOCIATES 16, L.P.

NEA PARTNERS 16, L.P.

NEA 16 GP, LLC

  • 10% Owner
10,714,285 2021-03-16 1

CHANG CARMEN

  • 10% Owner
10,714,285 2021-03-16 1

VERA JUAN CHIEF DEVELOPMENT OFFICER

  • Officer
2,564,487 2021-03-16 2

LOIACONO MICHAEL CHIEF ACCOUNTING OFFICER

  • Officer
0 2021-02-10 1

KIM ANTHONY H. CHIEF FINANCIAL OFFICER

  • Officer
0 2021-02-10 1

HOANG TSVETELINA P VP, RESEARCH AND DEVELOPMENT

  • Officer
0 2021-02-10 1

KONERU MYTHILI CHIEF MEDICAL OFFICER

  • Officer
0 2021-02-10 1

AGOPYAN NADIA VP, REGULATORY AFFAIRS

  • Officer
0 2021-02-10 1

SZYMANSKA ANNA VICE PRESIDENT, QUALITY

  • Officer
0 2021-02-10 1

GARRETT GERALD VICE PRESIDENT, CLINICAL OPS.

  • Officer
0 2021-02-10 1

EASTERN CAPITAL LTD

PORTFOLIO SERVICES LTD.

DART KENNETH BRYAN

  • 10% Owner
No longer subject to file 2020-11-09 1

LEEN ANN M. CHIEF SCIENTIFIC OFFICER

  • Officer
No longer subject to file 2020-02-15 0

MOSELEY KEN GENERAL COUNSEL

  • Officer
0 2018-12-21 0

BARRIS PETER J

  • 10% Owner
5,000,000 2018-10-17 0

MOTT DAVID M

  • 10% Owner
5,000,000 2018-10-17 0

VISWANATHAN RAVI

  • 10% Owner
5,000,000 2018-10-17 0

SILVERMAN JOSHUA

  • Director
No longer subject to file 2018-10-16 0

REDDISH MARK

  • Director
No longer subject to file 2018-10-16 0

GRISEWOOD SHERRY

  • Director
No longer subject to file 2018-10-16 0

WILSON GLYNN

  • Director
181,776 2018-10-09 0

BONFIGLIO JOHN N PRESIDENT AND COO

  • Officer
  • Director
36,471 2017-03-09 0

CORIN DENIS PRESIDENT AND CFO

  • Officer
  • Director
2,363,168 2011-03-23 0

DEPIPPO LYNN

  • Director
108,696 2010-09-07 0

MOORE TRACY A CHIEF FINANCIAL OFFICER

  • Officer
  • Director
500,000 2009-10-14 0

LINDSAY ALAN P

  • Director
0 2009-03-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
MARKER THERAPEUTICS INC MRKR 2021-09-21 20:15:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 19:45:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 19:15:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 18:45:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 18:15:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 17:45:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 17:15:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 16:45:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 16:15:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 15:45:04 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 15:15:04 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 14:45:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 14:15:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 13:45:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 13:15:03 UTC -0.7447 0.8147 1400000
MARKER THERAPEUTICS INC MRKR 2021-09-21 12:45:03 UTC -0.7447 0.8147 1300000
MARKER THERAPEUTICS INC MRKR 2021-09-20 22:15:03 UTC -0.7447 0.8147 1300000
MARKER THERAPEUTICS INC MRKR 2021-09-20 21:45:03 UTC -0.7447 0.8147 1300000
MARKER THERAPEUTICS INC MRKR 2021-09-20 21:15:04 UTC -0.7447 0.8147 1300000
MARKER THERAPEUTICS INC MRKR 2021-09-20 20:45:03 UTC -0.7447 0.8147 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments